Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$502K Hold
2,600
﹤0.01% 335
2026
Q1
$443K Buy
+2,600
New +$507K ﹤0.01% 339
2017
Q1
Sell
-3,930
Closed -$299K 354
2016
Q4
$299K Sell
3,930
-93,923
-96% -$7.2M ﹤0.01% 336
2016
Q3
$7.93M Sell
97,853
-7,658
-7% -$580K 0.13% 188
2016
Q2
$6.89M Sell
105,511
-193,678
-65% -$13M 0.12% 199
2016
Q1
$19.5M Buy
299,189
+2,560
+0.9% +$162K 0.34% 115
2015
Q4
$20.4M Buy
296,629
+5,431
+2% +$371K 0.38% 98
2015
Q3
$20.3M Buy
291,198
+29,613
+11% +$2.22M 0.34% 126
2015
Q2
$19M Buy
261,585
+63,960
+32% +$4.38M 0.29% 150
2015
Q1
$13.2M Buy
+197,625
New +$12.5M 0.2% 164

Other funds holding IQV

Boston Trust Walden's IQV Position: Q2 2026 in Review

Boston Trust Walden held its IQVIA (IQV) position steady in Q2 2026 at 2,600 shares worth $502K. The position accounts for ﹤0.01% of the portfolio, ranked #335.

Boston Trust Walden first reported a position in IQV in Q1 2015 and has held it in 10 quarters since. The position peaked at $20.4M in Q4 2015. 1,089 funds tracked by Wall St. Rank hold IQV as of Q2 2026.

  • Boston Trust Walden held 2,600 shares of IQVIA worth $502K as of Q2 2026.
  • Boston Trust Walden left its IQVIA share count unchanged in Q2 2026.
  • IQVIA made up ﹤0.01% of Boston Trust Walden's portfolio in Q2 2026, its #335 holding.
  • Boston Trust Walden first reported a position in IQVIA in Q1 2015 and has held it in 10 quarters since.
  • Boston Trust Walden's IQVIA position peaked at $20.4M in Q4 2015.
  • 1,089 funds tracked by Wall St. Rank held IQVIA as of Q2 2026.

Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.